Radiothérapie des sarcomes des tissus mous des membres : évolution technique et impact sur le bénéfice clinique - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Cancer/Radiothérapie Année : 2016

[Radiotherapy for soft tissue sarcomas: Technical evolution and impact on clinical benefit].

Radiothérapie des sarcomes des tissus mous des membres : évolution technique et impact sur le bénéfice clinique

Résumé

The standard treatment for extremity soft tissue sarcomas is based on the association of surgery and radiotherapy. This strategy allows local control improvement with the risk of increased toxicity. There is therefore a growing interest to identify those patients who will benefit from radiotherapy and those who will have the same local control with surgery alone. Furthermore, the development of toxicity has been correlated with the extension of the irradiated volume and the volume receiving high doses. Technological development as intensity modulated radiotherapy and image-guided radiotherapy allows limited irradiated volume improving the protection of the organs at risk leading to clinical benefit improvement. Moreover, efforts are being done to improve local control for the patients at high risk of local relapse. In this paper, we discuss all these mentioned aspects.
Fichier non déposé

Dates et versions

hal-02297528 , version 1 (26-09-2019)

Identifiants

Citer

C. Llacer-Moscardo, C. Bourgier, A. Morel, P. Fenoglietto, S. Carrere, et al.. Radiothérapie des sarcomes des tissus mous des membres : évolution technique et impact sur le bénéfice clinique. Cancer/Radiothérapie, 2016, 20 (6-7), pp.666-676. ⟨10.1016/j.canrad.2016.07.074⟩. ⟨hal-02297528⟩
35 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More